Evaluation of the antibacterial effect of nalidixic acid in two experimental models of Escherichia coli pyelonephritis.
D000818:Animals; D001431:Bacteriological Techniques; D004927:Escherichia coli Infections / Q000188:drug therapy*; D007275:Injections, Intravenous; D007668:Kidney / Q000473:pathology; D007684:Kidney Tubules / Q000473:pathology; D008297:Male; D009268:Nalidixic Acid / Q000627:therapeutic use*; D011704:Pyelonephritis / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D011817:Rabbits; D001743:Urinary Bladder / Q000473:pathology
D009268:Nalidixic Acid